SOPHiA GENETICS SA
SOPH
134 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Sep 22 8:02 PM | Ross MukenDirector, Chief Executive Officer | Sale | 422 | $8.33 | $3.5K | 670,229(D) | View → |
| Sep 21, 2026 | Sep 21 8:31 PM | GEORGE CARDOZA | Proposed Sale | 774 | $8.19 | $6.3K | — | View → |
| Sep 21, 2026 | Sep 21 8:27 PM | ROSS J MUKEN | Proposed Sale | 422 | $8.19 | $3.5K | — | View → |
| Sep 14, 2026 | Sep 16 8:01 PM | Philippe MenuChief Medical Officer | Sale | 5,000 | $7.88 | $39.4K | 208,387(D) | View → |
| Sep 14, 2026 | Sep 16 8:01 PM | Zhenyu XuChief Scientific Officer | Sale | 4,000 | $7.88 | $31.5K | 552,887(D) | View → |
| Sep 11, 2026 | Sep 14 8:01 PM | Well Daan VanChief Legal Officer | Sale | 6,168 | $7.63 | $47.1K | 338,884(D) | View → |
| Sep 10, 2026 | Sep 14 8:01 PM | Jurgi CamblongDirector, Executive Chairman | Sale | 8,500 | $7.66 | $65.1K | 3,435,822(D) | View → |
| Sep 11, 2026 | Sep 11 8:30 PM | DAAN GUIDO MARIA VAN WELL | Proposed Sale | 6,168 | $7.61 | $46.9K | — | View → |
| Sep 8, 2026 | Sep 10 8:02 PM | Kathy L HibbsDirector | Sale | 6,250 | $8.13 | $50.8K | 96,992(D) | View → |
| Aug 27, 2026 | Aug 31 8:02 PM | Zhenyu XuChief Scientific Officer | Sale | 10,000 | $8.91 | $89.1K | 556,887(D) | View → |
| Aug 27, 2026 | Aug 27 8:24 PM | ZHENYU XU | Proposed Sale | 14,000 | $8.53 | $119.4K | — | View → |
| Aug 25, 2026 | Aug 26 8:04 PM | Philippe MenuChief Medical Officer | Sale | 5,000 | $8.68 | $43.4K | 213,387(D) | View → |
| Aug 25, 2026 | Aug 26 8:04 PM | Kathy L HibbsDirector | Sale | 6,250 | $8.68 | $54.2K | 103,242(D) | View → |
| Aug 24, 2026 | Aug 26 8:03 PM | Abhimanyu VermaChief Technology Officer | Sale | 5,000 | $8.80 | $44.0K | 172,171(D) | View → |
| Aug 19, 2026 | Aug 26 8:03 PM | Abhimanyu VermaChief Technology Officer | Sale | 5,000 | $8.20 | $41.0K | 177,171(D) | View → |
| Aug 25, 2026 | Aug 25 8:44 PM | KATHY L HIBBS | Proposed Sale | 18,750 | $8.45 | $158.4K | — | View → |
| Aug 19, 2026 | Aug 21 8:02 PM | Manuela ValenteChief People Officer | Sale | 10,000 | $7.94 | $79.4K | 210,450(D) | View → |
| Aug 21, 2026 | Aug 21 8:01 PM | Zhenyu XuChief Scientific Officer | Sale | 5,408 | $8.40 | $45.4K | 566,887(D) | View → |
| Aug 20, 2026 | Aug 21 8:01 PM | Zhenyu XuChief Scientific Officer | Sale | 4,592 | $8.41 | $38.6K | 572,295(D) | View → |
| Aug 19, 2026 | Aug 21 8:01 PM | Zhenyu XuChief Scientific Officer | Sale | 10,000 | $7.94 | $79.4K | 576,887(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 8 12:46 PM | Abhimanyu VermaChief Technology Officer | Grant/Award | 119,760 | $5.04 | 119,760(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Abhimanyu VermaChief Technology Officer | Grant/Award | 119,760 | $5.04 | 119,760(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Ross MukenPresident | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Philippe MenuChief Medical Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Zhenyu XuChief Scientific Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Jurgi CamblongDirector, Chief Executive Officer | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Kevin PuylaertChief Sales Officer | Grant/Award | 82,335 | $5.04 | 82,335(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | George CardozaChief Financial Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Manuela ValenteChief People Officer | Grant/Award | 104,790 | $5.04 | 104,790(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Well Daan VanChief Legal Officer | Grant/Award | 142,216 | $5.04 | 142,216(D) | View → |
← Previous
Page 2 of 2